Balchem Encapsulates, a business segment of Balchem Corporation (Amex: BCP), announced today that they have been granted a patent for developing the technology to increase milk production in lactating dairy cows.The new patent, No. 6,106,871, marks Balchem's dominance as developers of the only proven rumen-protected choline supplement that is feed-delivered to pass safely through the animal's stomach and into the small intestine for maximum absorption. Their REASHURE(TM) Choline product incorporates this patented technology to effectively deliver essential nutrients needed for liver metabolism and fat processing during the transition period of dairy cows. The transition period, lasting from 3-4 weeks pre-calving to 30-50 days in lactation, is the critical period in a dairy cow's life.The results include overall improvement of herd health through a decrease in metabolic disorders and heightened animal productivity through an increase in milk production. In the past year, field results confirm that cows fed REASHURE showed a substantial improvement in milk yield of up to nine pounds daily."The technology behind the REASHURE product showed great promise when it was launched in 1999, and now one year later, it has surpassed everyone's expectations. Now Balchem is poised to change the scope of the world dairy industry with this unique technology and product pipeline," says Winston Samuels, Ph.D. vice president and general manager of Balchem Encapsulates."Balchem remains committed to the development of products that will revolutionize a $100 million sector of the dairy industry to help producers achieve increased herd productivity and revenue, resulting in a maximum return on their investment," says Dino Rossi, president and CEO of Balchem Corporation.